A detailed history of Ctc Alternative Strategies, Ltd. transactions in Becton Dickinson & CO stock. As of the latest transaction made, Ctc Alternative Strategies, Ltd. holds 1,200 shares of BDX stock, worth $272,532. This represents 0.12% of its overall portfolio holdings.

Number of Shares
1,200
Holding current value
$272,532
% of portfolio
0.12%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

BUY
$225.07 - $246.17 $270,084 - $295,404
1,200 New
1,200 $280 Million
Q2 2023

Aug 23, 2023

BUY
$238.39 - $265.32 $190,712 - $212,256
800 New
800 $211 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64.8B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Ctc Alternative Strategies, Ltd. Portfolio

Follow Ctc Alternative Strategies, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ctc Alternative Strategies, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Ctc Alternative Strategies, Ltd. with notifications on news.